Patents by Inventor Denis Callewaert

Denis Callewaert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10166270
    Abstract: The present invention discloses a composition and method for effecting various cytokines and NF-?B by administering an effective amount of a phyto-percolate composition to an individual. In various exemplary embodiments, the composition is claimed to be useful for the effective treatment of inflammation, cancer, and/or various infections including HIV by regulation of various interleukins, such as IL-10 and IL-2, and of transcription factors including NF-?B.
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: January 1, 2019
    Assignee: Zivo Bioscience, Inc.
    Inventors: Tiffany Thomas, Fazlul Sarkar, Denis Callewaert, Andrew Dahl, Enrique Martinez
  • Publication number: 20170360883
    Abstract: The present invention discloses a composition and method for effecting various cytokines and NF-?B by administering an effective amount of a phyto-percolate composition to an individual. In various exemplary embodiments, the composition is claimed to be useful for the effective treatment of inflammation, cancer, and/or various infections including HIV by regulation of various interleukins, such as IL-10 and IL-2, and of transcription factors including NF-?B.
    Type: Application
    Filed: December 2, 2014
    Publication date: December 21, 2017
    Inventors: Tiffany Thomas, Fazlul Sarkar, Denis Callewaert, Andrew Dahl, Enrique Martinez
  • Publication number: 20150157688
    Abstract: The present invention discloses a composition and method for effecting various cytokines and NF-?B by administering an effective amount of a phyto-percolate composition to an individual. In various exemplary embodiments, the composition is claimed to be useful for the effective treatment of inflammation, cancer, and/or various infections including HIV by regulation of various interleukins, such as IL-10 and IL-2, and of transcription factors including NF-?B.
    Type: Application
    Filed: December 2, 2014
    Publication date: June 11, 2015
    Inventors: Tiffany Thomas, Fazlul Sarkar, Denis Callewaert, Andrew Dahl, Enrique Martinez
  • Publication number: 20150072433
    Abstract: An example embodiment is an apparatus for measuring antioxidant presence comprising a solid media, and a reagent carried by the media, the reagent reactive with at least one antioxidant to cause changes in light that is incident upon the reagent while carried by the solid media.
    Type: Application
    Filed: November 12, 2014
    Publication date: March 12, 2015
    Inventors: Mustafa Resat Apak, Kubilay Guclu, Mustafa Ozyurek, Mustafa Bener, Enrique Martinez, Denis Callewaert
  • Patent number: 8912004
    Abstract: An example embodiment is an apparatus for measuring antioxidant presence comprising a solid media, and a reagent carried by the media, the reagent reactive with at least one antioxidant to cause changes in light that is incident upon the reagent while carried by the solid media.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: December 16, 2014
    Assignee: Oxford Biomedical Research, Inc.
    Inventors: Mustafa Resat Apak, Kubilay Guclu, Mustafa Ozyurek, Mustafa Bener, Enrique Martinez, Denis Callewaert
  • Publication number: 20140356972
    Abstract: An apparatus for estimating the concentration of an aldehyde comprising a solid medium; a nucleophilic aromatic compound held on the medium; and an acid held on the medium and a method for detecting the presence of an aldehyde in a sample with the apparatus in which the sample is exposed at room temperature to a test medium to catalyze the formation of optically detectable quantities of a product within a time period of no more than 60 minutes and without applying any external heat to the sample or test medium, the test medium comprising a indicator that is a nucleophilic compound having acidic protons at the nucleophilic center and at least one acid, and measuring the optical changes that occur as a result of the catalysis.
    Type: Application
    Filed: August 20, 2014
    Publication date: December 4, 2014
    Inventors: Enrique Martinez, II, Denis Callewaert, Donald J. VerLee
  • Patent number: 8846405
    Abstract: A method for detecting the presence of an aldehyde in a sample comprises steps of exposing the sample at room temperature to a test medium to catalyze the formation of optically detectable quantities of a product within a time period of no more than 60 minutes and without applying any external heat to the sample or test medium, the test medium comprising a indicator that is a nucleophilic compound having acidic protons at the nucleophilic center and at least one acid, and measuring the optical changes that occur as a result of the catalysis.
    Type: Grant
    Filed: July 16, 2012
    Date of Patent: September 30, 2014
    Assignee: Oxford Biomedical Research, Inc.
    Inventors: Enrique Martinez, II, Denis Callewaert, Donald J. VerLee
  • Publication number: 20140017800
    Abstract: A method for detecting the presence of an aldehyde in a sample comprises steps of exposing the sample at room temperature to a test medium to catalyze the formation of optically detectable quantities of a product within a time period of no more than 60 minutes and without applying any external heat to the sample or test medium, the test medium comprising a indicator that is a nucleophilic compound having acidic protons at the nucleophilic center and at least one acid, and measuring the optical changes that occur as a result of the catalysis.
    Type: Application
    Filed: July 16, 2012
    Publication date: January 16, 2014
    Inventors: Enrique Martinez II, Denis Callewaert, Donald J. VerLee
  • Publication number: 20130251698
    Abstract: The present invention discloses a composition and method for effecting various cytokines and NF-?B by administering an effective amount of a phyto-percolate composition to an individual. In various exemplary embodiments, the composition is claimed to be useful for the effective treatment of inflammation, cancer, and/or various infections including HIV by regulation of various interleukins, such as IL-10 and IL-2, and of transcription factors including NF-?B.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 26, 2013
    Applicant: Health Enhancement Products, Inc.
    Inventors: Tiffany Thomas, Fazlul Sarkar, Denis Callewaert, Andrew Dahl, Enrique Martinez
  • Publication number: 20120203465
    Abstract: One example embodiment of the invention is a system for collecting, measuring and outputting health data including a plurality of readers that each determine a plurality of different biomarker measurements from a bodily fluid sample, the test readers communicating test data sets over a network. A central computer is linked to each of the plurality of test readers and receives the test data set, the central computer associates at least a first security key with the test data set. The central computer responds to a first request for a test output report that includes the first security key and retrieves the corresponding test data set. The central computer prepares a test output report that includes a plurality of bodily fluid test measurements and transmits it over a network.
    Type: Application
    Filed: February 15, 2012
    Publication date: August 9, 2012
    Inventors: Denis Callewaert, Frank Lyman, Robert Smith